The stock price of ENDRA Life Sciences Inc (NASDAQ: NDRA) has dropped by -26.13 compared to previous close of 0.07. Despite this, the company has seen a fall of -32.52% in its stock price over the last five trading days. businesswire.com reported 2024-08-07 that ANN ARBOR, Mich.–(BUSINESS WIRE)—- $NDRA #NALFD–ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three and six months ended June 30, 2024 on Wednesday, August 14, 2024 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate develop.
Is It Worth Investing in ENDRA Life Sciences Inc (NASDAQ: NDRA) Right Now?
Additionally, the 36-month beta value for NDRA is 0.86. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for NDRA is 70.12M and currently, short sellers hold a 0.33% ratio of that float. The average trading volume of NDRA on August 09, 2024 was 21.76M shares.
NDRA’s Market Performance
NDRA’s stock has seen a -32.52% decrease for the week, with a -39.95% drop in the past month and a -82.72% fall in the past quarter. The volatility ratio for the week is 8.56%, and the volatility levels for the past 30 days are at 10.29% for ENDRA Life Sciences Inc. The simple moving average for the past 20 days is -34.21% for NDRA’s stock, with a -92.85% simple moving average for the past 200 days.
NDRA Trading at -51.07% from the 50-Day Moving Average
After a stumble in the market that brought NDRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.13% of loss for the given period.
Volatility was left at 10.29%, however, over the last 30 days, the volatility rate increased by 8.56%, as shares sank -34.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -77.57% lower at present.
During the last 5 trading sessions, NDRA fell by -22.71%, which changed the moving average for the period of 200-days by -94.01% in comparison to the 20-day moving average, which settled at $0.0779. In addition, ENDRA Life Sciences Inc saw -97.53% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NDRA
Current profitability levels for the company are sitting at:
- -24.19 for the present operating margin
- 0.39 for the gross margin
The net margin for ENDRA Life Sciences Inc stands at -23.09. The total capital return value is set at -2.7. Equity return is now at value -241.38, with -168.89 for asset returns.
Based on ENDRA Life Sciences Inc (NDRA), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -28.35. The debt to equity ratio resting at 0.09. The interest coverage ratio of the stock is 3031.58.
Currently, EBITDA for the company is -10.25 million with net debt to EBITDA at 0.08. When we switch over and look at the enterprise to sales, we see a ratio of 7.0. The receivables turnover for the company is -0.16for trailing twelve months and the total asset turnover is 0.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.04.
Conclusion
In conclusion, ENDRA Life Sciences Inc (NDRA) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
